Page last updated: 2024-10-27

foscarnet and Body Weight

foscarnet has been researched along with Body Weight in 1 studies

Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.

Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.

Research Excerpts

ExcerptRelevanceReference
"Foscarnet was started on day +1 after BMT and continued until day +100."6.69Foscarnet prophylaxis of cytomegalovirus infections in patients undergoing allogeneic bone marrow transplantation (BMT): a dose-finding study. ( Bacigalupo, A; Benvenuto, F; Berisso, G; Bertilson, S; Bregante, S; Figari, O; Gualandi, F; Lamparelli, T; Mordini, N; Raiola, AM; Tedone, E; Trespi, G; Van Lint, MT, 2000)
"Foscarnet was started on day +1 after BMT and continued until day +100."2.69Foscarnet prophylaxis of cytomegalovirus infections in patients undergoing allogeneic bone marrow transplantation (BMT): a dose-finding study. ( Bacigalupo, A; Benvenuto, F; Berisso, G; Bertilson, S; Bregante, S; Figari, O; Gualandi, F; Lamparelli, T; Mordini, N; Raiola, AM; Tedone, E; Trespi, G; Van Lint, MT, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bregante, S1
Bertilson, S1
Tedone, E1
Van Lint, MT1
Trespi, G1
Mordini, N1
Berisso, G1
Gualandi, F1
Lamparelli, T1
Figari, O1
Benvenuto, F1
Raiola, AM1
Bacigalupo, A1

Trials

1 trial available for foscarnet and Body Weight

ArticleYear
Foscarnet prophylaxis of cytomegalovirus infections in patients undergoing allogeneic bone marrow transplantation (BMT): a dose-finding study.
    Bone marrow transplantation, 2000, Volume: 26, Issue:1

    Topics: Adult; Antiviral Agents; Blood Pressure; Body Weight; Bone Marrow Transplantation; Cytomegalovirus I

2000